Key Trends Influencing the Growth of the Plasma Protein Therapeutics Market in 2025: Innovative Products Drive Competition In The Plasma Protein Therapeutics Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Plasma Protein Therapeutics Market Through 2025?
In recent times, there has been significant expansion in the plasma protein therapeutics market. This growth is expected to continue from $32.22 billion in 2024 to $34.68 billion in 2025, with a compound annual growth rate (CAGR) of 7.6%. Several factors have contributed to this historic growth, including the rising incidences of rare diseases, an increasing elderly population, a steady supply of global blood plasma, an escalation in hemophilia cases, advancements in diagnostic procedures, and a conducive regulatory atmosphere.

What's the Projected Size of the Global Plasma Protein Therapeutics Market by 2029?
The market size of plasma protein therapeutics is predicted to witness significant expansion in the upcoming years, potentially escalating to "$45.58 billion in 2029 with a cumulative annual growth rate (CAGR) of 7.1%. The surge during this projection period can be credited to progress in gene therapy, an increase in healthcare spending, widen indications, precision medicine strategies, and patient access programs. Prominent trends during this period could encompass technological breakthroughs, the uptake of telemedicine, advancements in plasma fractionation technology, the emergence of next-generation therapies, acceptance of recombinant therapies, and approaches to personalized medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/plasma-protein-therapeutics-global-market-report

Top Growth Drivers in the Plasma Protein Therapeutics Industry: What's Accelerating the Market?
The plasma protein therapeutics market is projected to expand due to the rising occurrences of autoimmune disorders. Autoimmune disorders occur when the body's immune system mistakenly assaults and eradicates healthy bodily cells. Such diseases, which are treated using therapeutic plasma exchange, arise when the body falsely deems a section of itself as foreign and generates proteins (referred to as autoantibodies) that target the misidentified part. For instance, a study by the University of Glasgow-a public university in the UK-that involved 22 million people, discovered that autoimmune disorders impact approximately 10% of the UK's population, surpassing prior predictions. Thus, the escalating rate of autoimmune disorders is a major factor contributing to the growth of the plasma protein therapeutics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9213&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Plasma Protein Therapeutics Market?
Key product innovations are becoming a trending aspect in the plasma protein therapeutic market. Many leading firms in this sector are concentrating on these innovative products to have a market edge. For example, in October 2023, Switzerland-based Octapharma AG earned approval from European medical regulators for the lyophilized form of its widely known product, octaplasLG. This new formulation is meant for pre-hospital transfusion, offering medical professionals a practical and effective choice for handling critical situation patients. Octapharma's dedication to augmenting patient care through inventive solutions in blood product domain is accentuated through this approval.

What Are the Main Segments in the Plasma Protein Therapeutics Market?
The plasma protein therapeutics market covered in this report is segmented -

1) By Product: Immunoglobulin, Albumin, Coagulation Factor, C1-esterase Inhibitors, Other Products
2) By Route Of Administration: Intravenous, Subcutaneous
3) By Applications: Primary Immunodeficiency Disorder (PID), Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency, Hereditary Angioedema, Other Applications

Subsegments:
1) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)
2) By Albumin: Human Serum Albumin, Recombinant Albumin
3) By Coagulation Factor: Factor VIII, Factor IX, Prothrombin Complex Concentrates
4) By C1-Esterase Inhibitors: Human C1-Esterase Inhibitors, Recombinant C1-Esterase Inhibitors
5) By Other Products: Fibrinogen, Alpha-1 Antitrypsin, Clotting Factor Concentrates

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9213&type=smp

Which Top Companies are Driving Growth in the Plasma Protein Therapeutics Market?
Major companies operating in the plasma protein therapeutics market include CSL Behring LLC, Grifols SA, China Biologic Products Holdings Inc., Takeda Pharmaceutical Company Limited, Baxter International Inc., Kedrion SpA, LFB SA, Emergent BioSolutions Inc., Reliance Life Sciences Private Limited, ADMA Biologics Inc., Prothya Biosolutions BV, Bio Products Laboratory Ltd., Biotest AG, Taibang Biological Group Co Ltd, Octapharma Plasma Inc., New York Blood Center, Green Cross Corporation, China National Biotec Group Company Limited, Kamada Ltd., Australian Red Cross Lifeblood

Which Regions Will Dominate the Plasma Protein Therapeutics Market Through 2029?
North America was the largest region in the plasma protein therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plasma protein therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9213

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.